Catalyst Wire Dossier Catalyst Wire Dossier

Sapacitabine

sapacitabine · Cyclacel Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Sapacitabine, covering 2019-07-16 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Olaparib + Sapacitabine in BRCA Mutant Breast Cancer [Phase 1]

See pricing